| 1 minute
£11m boost for leading Scottish antibody development company
Edinburgh-based biotechnology company MedAnnex Ltd has received a further £1m investment from The Scottish Investment Bank (SIB), the investment arm of Scotland’s national economic development agency, Scottish Enterprise.
This adds to a recent £10m Series B investment, by Boston-based global Life Sciences investor Morningside Ventures, to close an £11m funding round for MedAnnex.
Please see here:
For further coverage, please see here: